Index S&P 500
P/E 30.33
EPS (ttm) 6.50
Insider Own 0.75%
Shs Outstand 147.06M
Perf Week -3.01%
Market Cap 28.95B
Forward P/E 22.45
EPS next Y 8.78
Insider Trans -7.06%
Shs Float 145.80M
Perf Month 5.63%
Income 958.38M
PEG 2.33
EPS next Q 2.08
Inst Own 59.13%
Short Float 5.82%
Perf Quarter 7.43%
Sales 4.58B
P/S 6.31
EPS this Y 20.07%
Inst Trans -0.38%
Short Ratio 7.80
Perf Half Y 5.74%
Book/sh 31.52
P/B 6.25
EPS next Y 13.48%
ROA 14.17%
Short Interest 8.48M
Perf Year -11.10%
Cash/sh 1.62
P/C 121.67
EPS next 5Y 13.00%
ROE 22.39%
52W Range 132.24 - 229.97
Perf YTD 14.54%
Dividend Est. 1.95 (0.99%)
P/FCF 26.57
EPS past 5Y 22.66%
ROI 16.63%
52W High -14.32%
Beta 0.65
Dividend TTM 1.92 (0.97%)
Quick Ratio 1.97
Sales past 5Y 12.88%
Gross Margin 54.74%
52W Low 49.00%
ATR (14) 5.93
Dividend Ex-Date May 08, 2024
Current Ratio 3.04
EPS Y/Y TTM 10.74%
Oper. Margin 28.12%
RSI (14) 44.27
Volatility 3.19% 2.55%
Employees 10140
Debt/Eq 0.25
Sales Y/Y TTM 14.16%
Profit Margin 20.91%
Recom 1.96
Target Price 224.01
Option/Short Yes / Yes
LT Debt/Eq 0.24
EPS Q/Q 29.19%
Payout 28.91%
Rel Volume 1.74
Prev Close 208.34
Sales Surprise 1.94%
EPS Surprise 10.51%
Sales Q/Q 7.17%
Earnings Aug 01 AMC
Avg Volume 1.09M
Price 197.04
SMA20 -0.99%
SMA50 -4.06%
SMA200 7.95%
Trades
Volume 1,889,587
Change -5.42%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-25-24 Downgrade
Oppenheimer
Outperform → Perform
Jun-24-24 Downgrade
Citigroup
Buy → Neutral
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$227
Oct-27-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$180 → $169
Oct-12-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$273 → $202
Oct-09-23 Upgrade
JP Morgan
Neutral → Overweight
$210 → $170
Sep-29-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-06-23 Upgrade
Needham
Hold → Buy
$180
Sep-05-23 Downgrade
UBS
Buy → Neutral
$265 → $170
Aug-01-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$262 → $284
May-23-23 Initiated
UBS
Buy
$290
Apr-14-23 Initiated
Mizuho
Buy
$255
Jan-17-23 Upgrade
JP Morgan
Neutral → Overweight
$245
Oct-28-22 Downgrade
Citigroup
Buy → Neutral
Oct-20-22 Upgrade
BofA Securities
Neutral → Buy
$245 → $260
Oct-12-22 Initiated
Jefferies
Hold
Sep-08-22 Upgrade
Citigroup
Neutral → Buy
Aug-15-22 Downgrade
CLSA
Buy → Outperform
Aug-12-22 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$246 → $252
Aug-12-22 Downgrade
JP Morgan
Overweight → Neutral
Show Previous Ratings
Jul-25-24 10:01AM
Jul-11-24 09:45AM
01:30AM
Jul-10-24 01:29AM
Jul-05-24 09:00AM
04:05PM
Loading…
Jul-03-24 04:05PM
Jul-02-24 01:47PM
Jul-01-24 01:38AM
Jun-29-24 09:00AM
Jun-27-24 12:01PM
Jun-24-24 05:07PM
04:10PM
(Investor's Business Daily)
04:08PM
02:10PM
02:01PM
01:26PM
Loading…
01:26PM
12:52PM
(Associated Press Finance)
12:29PM
10:38AM
10:36AM
08:40AM
(The Wall Street Journal)
07:52AM
07:49AM
Jun-21-24 05:05PM
Jun-19-24 09:45AM
Jun-11-24 07:02PM
Jun-10-24 09:05AM
Jun-06-24 09:50AM
May-31-24 12:45PM
09:45AM
11:28AM
Loading…
May-27-24 11:28AM
May-23-24 09:05AM
06:00AM
May-21-24 09:30AM
May-20-24 10:47AM
May-16-24 04:35PM
12:00PM
08:05AM
May-15-24 12:45PM
09:45AM
May-08-24 10:31AM
May-07-24 04:05PM
May-03-24 09:43AM
Apr-30-24 01:31PM
09:50AM
Apr-29-24 12:45PM
09:45AM
Apr-27-24 01:06AM
Apr-26-24 04:08PM
(Investor's Business Daily) +18.89%
03:57PM
02:12PM
01:48PM
12:17PM
12:08PM
11:45AM
(The Wall Street Journal)
11:35AM
11:26AM
11:01AM
10:33AM
10:12AM
10:00AM
(Investor's Business Daily)
08:58AM
08:47AM
08:37AM
08:07AM
07:53AM
06:39AM
06:33AM
(Thomson Reuters StreetEvents)
06:16AM
03:36AM
Apr-25-24 06:30PM
05:43PM
05:25PM
04:49PM
04:22PM
(Associated Press Finance)
04:05PM
11:34AM
Apr-22-24 09:16AM
Apr-18-24 04:02PM
(Investor's Business Daily)
10:01AM
Apr-17-24 06:51PM
04:09PM
(Investor's Business Daily)
12:08PM
09:43AM
(The Wall Street Journal)
Apr-04-24 04:05PM
Apr-01-24 12:44PM
Mar-30-24 11:49AM
Mar-15-24 03:05AM
Mar-07-24 09:45AM
07:33AM
Mar-06-24 09:05AM
Feb-24-24 03:10AM
Feb-23-24 11:30AM
Feb-22-24 09:53AM
Feb-20-24 01:35PM
Feb-18-24 01:26PM
Feb-16-24 10:26AM
10:00AM
(The Wall Street Journal)
Feb-13-24 10:23AM
Feb-12-24 04:16PM
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Farrell Michael J. Chief Executive Officer Jul 08 '24 Option Exercise 84.98 14,683 1,247,761 455,482 Jul 10 12:04 PM Farrell Michael J. Chief Executive Officer Jul 08 '24 Sale 192.97 14,683 2,833,330 440,799 Jul 10 12:04 PM Sandercock Brett Chief Financial Officer Jul 08 '24 Sale 194.35 1,000 194,350 90,056 Jul 09 05:27 PM Sandercock Brett Chief Financial Officer Jun 10 '24 Sale 209.81 1,000 209,810 91,056 Jun 11 05:05 PM Farrell Michael J. Chief Executive Officer Jun 07 '24 Option Exercise 84.98 14,683 1,247,761 455,482 Jun 10 09:58 PM Farrell Michael J. Chief Executive Officer Jun 07 '24 Sale 211.66 14,683 3,107,739 440,799 Jun 10 09:58 PM De Witte Jan Director May 15 '24 Sale 218.29 360 78,584 7,519 May 17 11:27 AM Sandercock Brett Chief Financial Officer May 08 '24 Option Exercise 101.64 12,000 1,219,680 105,056 May 10 03:21 PM Sandercock Brett Chief Financial Officer May 08 '24 Sale 211.37 13,000 2,747,810 92,056 May 10 03:21 PM Farrell Michael J. Chief Executive Officer May 07 '24 Option Exercise 84.98 14,683 1,247,761 455,435 May 09 11:58 AM Farrell Michael J. Chief Executive Officer May 07 '24 Sale 216.50 14,683 3,178,815 440,752 May 09 11:58 AM Drexler Karen Director Apr 29 '24 Sale 214.92 425 91,341 8,446 Apr 30 02:17 PM Rider Michael J Global General Counsel Mar 04 '24 Sale 180.00 81 14,580 6,607 Mar 06 08:46 PM Rider Michael J Global General Counsel Mar 01 '24 Sale 173.25 200 34,650 6,688 Mar 04 07:11 PM FARRELL PETER C Director Feb 22 '24 Sale 182.66 10,935 1,997,434 157,404 Feb 23 06:40 PM Sandercock Brett Chief Financial Officer Nov 27 '23 Sale 152.62 3,000 457,860 92,962 Nov 29 07:45 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Option Exercise 57.76 5,678 327,961 446,664 Nov 16 09:20 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Sale 152.04 5,678 863,281 440,986 Nov 16 09:20 PM Rider Michael J Global General Counsel Nov 01 '23 Sale 143.42 25 3,585 7,358 Nov 02 09:29 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Option Exercise 57.76 5,675 327,788 455,035 Oct 17 06:50 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Sale 140.70 5,675 798,464 449,360 Oct 17 06:50 PM Rider Michael J Global General Counsel Oct 02 '23 Sale 145.92 25 3,648 7,383 Oct 04 10:57 AM Farrell Michael J. Chief Executive Officer Sep 15 '23 Option Exercise 57.76 5,675 327,788 455,035 Sep 19 02:54 PM Farrell Michael J. Chief Executive Officer Sep 15 '23 Sale 146.35 5,675 830,514 449,360 Sep 19 02:54 PM Rider Michael J Global General Counsel Sep 01 '23 Sale 161.15 25 4,029 7,408 Sep 07 03:44 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Option Exercise 57.76 5,675 327,788 442,605 Aug 17 01:39 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Sale 183.20 5,675 1,039,647 436,930 Aug 17 01:39 PM Douglas Robert Andrew President and COO Aug 15 '23 Sale 181.01 1,500 271,515 250,526 Aug 16 01:51 PM Rider Michael J Global General Counsel Aug 01 '23 Sale 224.12 25 5,603 5,186 Aug 02 05:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite